53 related articles for article (PubMed ID: 12479091)
21. High-throughput tissue microarray analysis of G1-cyclin alterations in classical Hodgkin's lymphoma indicates overexpression of cyclin E1.
Tzankov A; Zimpfer A; Lugli A; Krugmann J; Went P; Schraml P; Maurer R; Ascani S; Pileri S; Geley S; Dirnhofer S
J Pathol; 2003 Feb; 199(2):201-7. PubMed ID: 12533833
[TBL] [Abstract][Full Text] [Related]
22. A novel immunohistochemical method to estimate cell-cycle phase distribution in archival tissue: implications for the prediction of outcome in colorectal cancer.
Scott IS; Morris LS; Bird K; Davies RJ; Vowler SL; Rushbrook SM; Marshall AE; Laskey RA; Miller R; Arends MJ; Coleman N
J Pathol; 2003 Oct; 201(2):187-97. PubMed ID: 14517835
[TBL] [Abstract][Full Text] [Related]
23. Growth inhibition of K562 cells by cyclin E gene-specific small interfering RNA.
Song HX; Ma WL; Song YB; Zhang B; Zheng WL
Di Yi Jun Yi Da Xue Xue Bao; 2005 Apr; 25(4):361-5. PubMed ID: 15837628
[TBL] [Abstract][Full Text] [Related]
24. Prognostic implication of cyclin E expression and its relationship with cyclin D1 and p27Kip1 expression on tissue microarrays of node negative breast cancer.
Han S; Park K; Bae BN; Kim KH; Kim HJ; Kim YD; Kim HY
J Surg Oncol; 2003 Aug; 83(4):241-7. PubMed ID: 12884237
[TBL] [Abstract][Full Text] [Related]
25. [Inhibitory effect of WT1 gene isoform transfection on proliferation of leukemia cell line NB4].
Shen HL; Chen ZX; Wang W; Cen JN; Hu SY; Zhao Y
Ai Zheng; 2006 Feb; 25(2):163-9. PubMed ID: 16480579
[TBL] [Abstract][Full Text] [Related]
26. Cyclin E expression is correlated with tumor progression and predicts a poor prognosis in patients with ovarian carcinoma.
Rosen DG; Yang G; Deavers MT; Malpica A; Kavanagh JJ; Mills GB; Liu J
Cancer; 2006 May; 106(9):1925-32. PubMed ID: 16568440
[TBL] [Abstract][Full Text] [Related]
27. 4-1BB enhances CD8+ T cell expansion by regulating cell cycle progression through changes in expression of cyclins D and E and cyclin-dependent kinase inhibitor p27kip1.
Lee HW; Nam KO; Park SJ; Kwon BS
Eur J Immunol; 2003 Aug; 33(8):2133-41. PubMed ID: 12884287
[TBL] [Abstract][Full Text] [Related]
28. Prognostic implication of CDC25A and cyclin E expression on primary breast cancer patients.
Mehdipour P; Pirouzpanah S; Sarafnejad A; Atri M; Shahrestani ST; Haidari M
Cell Biol Int; 2009 Oct; 33(10):1050-6. PubMed ID: 19555767
[TBL] [Abstract][Full Text] [Related]
29. Cyclin E expression is a significant predictor of survival in advanced, suboptimally debulked ovarian epithelial cancers: a Gynecologic Oncology Group study.
Farley J; Smith LM; Darcy KM; Sobel E; O'Connor D; Henderson B; Morrison LE; Birrer MJ;
Cancer Res; 2003 Mar; 63(6):1235-41. PubMed ID: 12649182
[TBL] [Abstract][Full Text] [Related]
30. Small interference RNA-mediated suppression of overexpressed cyclin E protein restores G1/S regulation in NIH-OVCAR-3 ovarian cancer cells.
Todd MC; Spruill SC; Meerbrey KL
Int J Oncol; 2009 Aug; 35(2):375-80. PubMed ID: 19578752
[TBL] [Abstract][Full Text] [Related]
31. Cycloheximide protects HepG2 cells from serum withdrawal-induced apoptosis by decreasing p53 and phosphorylated p53 levels.
Bai J; Cederbaum AI
J Pharmacol Exp Ther; 2006 Dec; 319(3):1435-43. PubMed ID: 16971506
[TBL] [Abstract][Full Text] [Related]
32. [Effect of telomerase on ginsenoside Rh2-induced differentiation of hepatocarcinoma cell line SMMC-7721].
Zeng XL; Tu ZG
Ai Zheng; 2004 Dec; 23(12):1655-9. PubMed ID: 15601555
[TBL] [Abstract][Full Text] [Related]
33. Induction of centrosome amplification and chromosome instability in human bladder cancer cells by p53 mutation and cyclin E overexpression.
Kawamura K; Izumi H; Ma Z; Ikeda R; Moriyama M; Tanaka T; Nojima T; Levin LS; Fujikawa-Yamamoto K; Suzuki K; Fukasawa K
Cancer Res; 2004 Jul; 64(14):4800-9. PubMed ID: 15256449
[TBL] [Abstract][Full Text] [Related]
34. Leukotriene B4 receptor antagonist LY293111 induces S-phase cell cycle arrest and apoptosis in human pancreatic cancer cells.
Tong WG; Ding XZ; Talamonti MS; Bell RH; Adrian TE
Anticancer Drugs; 2007 Jun; 18(5):535-41. PubMed ID: 17414622
[TBL] [Abstract][Full Text] [Related]
35. Cepharanthine exerts antitumor activity on oral squamous cell carcinoma cell lines by induction of p27Kip1.
Harada K; Supriatno ; Yamamoto S; Kawaguchi S; Yoshida H; Sato M
Anticancer Res; 2003; 23(2B):1441-8. PubMed ID: 12820407
[TBL] [Abstract][Full Text] [Related]
36. Cyclin E and Bcl-xL cooperatively induce cell cycle progression in c-Rel-/- B cells.
Cheng S; Hsia CY; Leone G; Liou HC
Oncogene; 2003 Nov; 22(52):8472-86. PubMed ID: 14627988
[TBL] [Abstract][Full Text] [Related]
37. Low-molecular weight forms of cyclin E differentiate ovarian carcinoma from cells of mesothelial origin and are associated with poor survival in ovarian carcinoma.
Davidson B; Skrede M; Silins I; Shih IeM; Trope CG; Flørenes VA
Cancer; 2007 Sep; 110(6):1264-71. PubMed ID: 17647260
[TBL] [Abstract][Full Text] [Related]
38. Significance of cyclin E and p27 expression in malignant ovarian germ cell tumors: correlation with the cell proliferation activity and clinicopathologic features.
Kawauchi S; Yamamoto Y; Uchida K; Chochi Y; Kondo T; Oga A; Sasaki K
Oncol Rep; 2006 Nov; 16(5):1029-33. PubMed ID: 17016588
[TBL] [Abstract][Full Text] [Related]
39. Timing the changes of cyclin E cell content in G1 in exponentially growing cells.
Tomasoni D; Lupi M; Brikci FB; Ubezio P
Exp Cell Res; 2003 Aug; 288(1):158-67. PubMed ID: 12878167
[TBL] [Abstract][Full Text] [Related]
40. The frostration threshold.
SHERMAN M
Am J Psychiatry; 1947 Oct; 104(4):242-6. PubMed ID: 18896723
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
